SCHEMBL2126730

SCHEMBL2126730

CCSSCCCSSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10947641 0.87
SCHEMBL10943263 0.84
SCHEMBL19597429 0.82
SCHEMBL14524398 0.82
SCHEMBL10948165 0.78
SCHEMBL10945804 0.78
SCHEMBL10943798 0.78
SCHEMBL10947162 0.78
SCHEMBL575853 0.75
SCHEMBL575889 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160376591-A1 iRNA AGENTS WITH BIOCLEAVABLE TETHERS BANK OF AMERICA, N.A. 2016-12-29 US disclosed
US-9476045-B2 iRNA agents with biocleavable tethers ALNYLAM PHARMACEUTICALS, INC. (US) 2016-10-25 US disclosed
US-20150073133-A1 iRNA AGENTS WITH BIOCLEAVABLE TETHERS BANK OF AMERICA, N.A. 2015-03-12 US disclosed
US-8865677-B2 iRNA agents with biocleavable tethers ALNYLAM PHARMACEUTICALS, INC. (US) 2014-10-21 US disclosed
EP-2444532-B1 IODINE- AND AMYLOSE-CONTAINING FIBERS, METHOD FOR PRODUCTION THEREOF, AND USE THEREOF OMIKENSHI KK (JP) 2014-07-23 EP disclosed
US-20130281685-A1 iRNA AGENTS WITH BIOCLEAVABLE TETHERS BANK OF AMERICA, N.A. 2013-10-24 US disclosed
US-8426377-B2 iRNA agents with biocleavable tethers ALNYLAM PHARMACEUTICALS, INC. (US) 2013-04-23 US disclosed
EP-2444532-A1 IODINE- AND AMYLASE-CONTAINING FIBERS, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF Omikenshi Co., Ltd. (JP) 2012-04-25 EP disclosed
US-20100267941-A1 IRNA AGENTS WITH BIOCLEAVABLE TETHERS ALNYLAM PHARMACEUTICALS, INC. (US) 2010-10-21 US disclosed